Insider Transactions in Q2 2022 at Pmv Pharmaceuticals, Inc. (PMVP)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 26
2022
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
26,253
-23.02%
|
$393,795
$15.93 P/Share
|
|
Apr 27
2022
|
David Henry Mack President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,000
+29.21%
|
$0
$0.53 P/Share
|
|
Apr 20
2022
|
Winston Kung COO, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+27.4%
|
$12,000
$3.22 P/Share
|